These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6516893)

  • 1. High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163).
    Dajas F; Lista A; Barbeito L
    Acta Psychiatr Scand; 1984 Nov; 70(5):432-7. PubMed ID: 6516893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
    Casacchia M; Carolei A; Barba C; Frontoni M; Rossi A; Meco G; Zylberman MR
    Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical study of the selective MAO-A-inhibitor moclobemide (Ro 11-1163): a comparison of 2 different dosages with particular reference to platelet MAO-activity and urinary MHPG-excretion.
    Lensch K; Fuchs G; Böning J; Milech U
    Int Clin Psychopharmacol; 1987 Apr; 2(2):165-71. PubMed ID: 3298420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression.
    Gabelic I; Kuhn B
    Acta Psychiatr Scand Suppl; 1990; 360():63. PubMed ID: 2248076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression.
    Gabelic I; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():44-5. PubMed ID: 2248068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
    Classen W
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
    Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
    Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and senile dementia of the Alzheimer type: a role for moclobemide.
    Chan-Palay V
    Psychopharmacology (Berl); 1992; 106 Suppl():S137-9. PubMed ID: 1546130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
    Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
    Gachoud JP; Dick P; Köhler M
    Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
    Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of moclobemide and imipramine in treatment of depression.
    Casacchia M; Rossi A
    Pharmacopsychiatry; 1989 Jul; 22(4):152-5. PubMed ID: 2668979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six months.
    Gagiano CA; Müller FG; de Kock RF; Schall R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):46S-50S. PubMed ID: 7593731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
    Pancheri P; Delle Chiaie R; Donnini M; Seripa S; Gambino C; Vicario E; Trillo L
    Clin Neuropharmacol; 1994; 17 Suppl 1():S58-73. PubMed ID: 7954485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moclobemide versus fluoxetine for major depressive episodes.
    Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
    Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of sleep questionnaires in assessing the effect of moclobemide on the sleep profiles of depressive patients.
    Campos JA; Deitos TF; Lima MC; Salomão K; Salomão S; Souza AC
    Clin Neuropharmacol; 1994; 17 Suppl 1():S19-28. PubMed ID: 7954481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.